SporosPolicy Intelligence

Federal Bills

Browse bills from the 119th Congress

State BillsNew

Legislation across all 50 states

Committees

Congressional committees & membership

Executive Orders

Directives from the President

AdministrationSoon

Cabinet members and appointees

Regulations

Federal rules and proposed rules

Agencies

Browse federal agencies

Members of Congress

Senators, representatives & delegates

Pricing

Free and paid plans

Learn

How the U.S. government works

Blog

Guides and analysis

Dashboard

Talk to us

Your feedback directly shapes Sporos.

S 3716: A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions. | Sporos

← Back to Bills

← S 3722Prev S 3704Next →

S 3716SenateBillIn Committee

A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.

Introduced

Jan 28, 2026

Last Action

Jan 28, 2026

Session

119th Congress

AI Summary

Get a plain-English explanation of what this bill does, who it affects, and why it matters.

Estimate based on legislative signals

See what factors are driving this score — cosponsor support, bipartisan backing, committee progress, and more.

Upgrade to Pro

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Baldwin, Tammy

←

S 3722

Previous Bill

S 3704

Next Bill

→

Talk to us

A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.

AI Summary

Passage Probability

Status

Sponsor